InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Jones Bryan. Director active across 1 company, notably Aardvark Therapeutics, Inc.. In total, 1 disclosures have been recorded. Activity tracked since 15 October 2025. The latest transaction was disclosed on 15 October 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration